| Dr Stephanie Diane Burleson, DO | |
|
11911 S Memorial Dr, Bixby, OK 74008-2030 | |
| (918) 497-3700 | |
| Not Available |
| Full Name | Dr Stephanie Diane Burleson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 11911 S Memorial Dr, Bixby, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457556474 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4280 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
| Saint Francis Hospital South, Llc | Tulsa, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Warren Clinic Inc | 8820900293 | 604 |
News Archive
Ocular Therapeutix announced today it has received approval from the Food and Drug Administration to commercialize the ReSure Sealant in the United States, with an indication for prevention of postoperative fluid egress from incisions with a demonstrated wound leak following cataract surgery.
Intermittent androgen deprivation (IAD) is commonly used in the treatment of CaP, which theoretically may delay the development of hormone resistance.
A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered that the protein pp32 – which normally applies the brakes on a cancer-causing gene – is missing in an aggressive form of pancreatic cancer.
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of its PinAAcle™ series atomic absorption spectrometers for determining the concentration of inorganic elements in a wide variety of sample types.
› Verified 7 days ago
| Entity Name | Warren Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174582282 PECOS PAC ID: 8820900293 Enrollment ID: O20031104000252 |
News Archive
Ocular Therapeutix announced today it has received approval from the Food and Drug Administration to commercialize the ReSure Sealant in the United States, with an indication for prevention of postoperative fluid egress from incisions with a demonstrated wound leak following cataract surgery.
Intermittent androgen deprivation (IAD) is commonly used in the treatment of CaP, which theoretically may delay the development of hormone resistance.
A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered that the protein pp32 – which normally applies the brakes on a cancer-causing gene – is missing in an aggressive form of pancreatic cancer.
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of its PinAAcle™ series atomic absorption spectrometers for determining the concentration of inorganic elements in a wide variety of sample types.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephanie Diane Burleson, DO 6600 S Yale Ave, Suite 1400, Tulsa, OK 74136-3347 Ph: (918) 488-6001 | Dr Stephanie Diane Burleson, DO 11911 S Memorial Dr, Bixby, OK 74008-2030 Ph: (918) 497-3700 |
News Archive
Ocular Therapeutix announced today it has received approval from the Food and Drug Administration to commercialize the ReSure Sealant in the United States, with an indication for prevention of postoperative fluid egress from incisions with a demonstrated wound leak following cataract surgery.
Intermittent androgen deprivation (IAD) is commonly used in the treatment of CaP, which theoretically may delay the development of hormone resistance.
A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered that the protein pp32 – which normally applies the brakes on a cancer-causing gene – is missing in an aggressive form of pancreatic cancer.
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of its PinAAcle™ series atomic absorption spectrometers for determining the concentration of inorganic elements in a wide variety of sample types.
› Verified 7 days ago
Ray E Stowers I, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6620 E 117th St S, Bixby, OK 74008 Phone: 918-269-1085 | |
Summer Anne Fillmore, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11911 S Memorial Dr, Bixby, OK 74008 Phone: 918-369-3200 Fax: 918-369-3205 | |
Christin Baker-hankton, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12620 S Memorial Dr, Bixby, OK 74008 Phone: 918-574-0150 | |
Dr. Cedric Michael Griffin, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7333 E 121st St S Ste 200, Bixby, OK 74008 Phone: 918-403-7140 Fax: 918-856-5392 | |
Terry L Mills, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 7333 E 121st St S, Bixby, OK 74008 Phone: 918-403-7140 Fax: 918-856-5392 | |
Julie Vang Broaddrick, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11911 S Memorial Dr, Bixby, OK 74008 Phone: 918-943-3790 |